Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling

Aim: Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality and is characterized by T-cell exhaustion, particularly in effector CD8+ T-cells. This exhaustion, driven by persistent immunosuppressive signals in the tumor microenvironment, impairs immune function and hin...

Full description

Saved in:
Bibliographic Details
Main Authors: Rawaa AlChalabi, Raghda Makia, Semaa A. Shaban, Ahmed AbdulJabbar Suleiman
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2025-01-01
Series:Exploration of Immunology
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A1003179/1003179.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586132851785728
author Rawaa AlChalabi
Raghda Makia
Semaa A. Shaban
Ahmed AbdulJabbar Suleiman
author_facet Rawaa AlChalabi
Raghda Makia
Semaa A. Shaban
Ahmed AbdulJabbar Suleiman
author_sort Rawaa AlChalabi
collection DOAJ
description Aim: Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality and is characterized by T-cell exhaustion, particularly in effector CD8+ T-cells. This exhaustion, driven by persistent immunosuppressive signals in the tumor microenvironment, impairs immune function and hinders effective immunotherapy. This study aimed to identify key exhaustion-related marker genes in CD8+ T-cells linked to PDAC and assess the potential of repurposing anti-inflammatory drugs to counteract T-cell exhaustion and enhance immune responses against PDAC. Methods: We employed a multi-omics approach, integrating single-cell RNA sequencing data with whole genome sequencing to identify dysregulated exhaustion-related immune markers in CD8+ T-cells in PDAC. We examined gene expression profiles and conducted functional enrichment analysis to evaluate their roles in immune exhaustion. We analyzed mutations in the shortlisted biomarkers from The Cancer Genome Atlas (TCGA) and performed in silico mutational analysis using Maestro to evaluate the impact of an IL7R mutation (K110N) on protein function. Virtual screening using a deep learning framework, GNINA, explored the inhibitory features of the anti-inflammatory drugs oxaprozin and celecoxib on IL7R. Results: Key dysregulated exhaustion-related immune markers were identified including PRF1, GZMA, CD8A, CD3D, NKG7, IL7R, and IL2RG. Pathway enrichment analysis indicated significant involvement in T-cell receptor signaling, Th1 and Th2 differentiation, and Th17 differentiation pathways, correlating with reported poor survival outcomes in PDAC patients. Mutational analysis of IL7R revealed a likely pathogenic mutation (K110N) located in the IL-7Ralpha fibronectin type III domain. Drug repurposing of oxaprozin and celecoxib showed favorable binding interactions with both wild and mutant IL7R proteins. Conclusions: The K110N mutation, despite not causing significant structural changes, may impact T-cell and B-cell homeostasis and development. Our findings suggest that oxaprozin and celecoxib could effectively inhibit T-cell exhaustion through favorable interactions with IL7R. Further clinical studies are necessary to validate the therapeutic potential of these anti-inflammatory drugs in enhancing immune responses in pancreatic cancer.
format Article
id doaj-art-70c8b48dd8c34251bc83412d329b2cbf
institution Kabale University
issn 2768-6655
language English
publishDate 2025-01-01
publisher Open Exploration Publishing Inc.
record_format Article
series Exploration of Immunology
spelling doaj-art-70c8b48dd8c34251bc83412d329b2cbf2025-01-26T08:36:44ZengOpen Exploration Publishing Inc.Exploration of Immunology2768-66552025-01-015100317910.37349/ei.2025.1003179Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profilingRawaa AlChalabi0https://orcid.org/0000-0002-1570-2537Raghda Makia1https://orcid.org/0000-0002-1490-7469Semaa A. Shaban2https://orcid.org/0000-0002-0538-8716Ahmed AbdulJabbar Suleiman3https://orcid.org/0000-0001-7427-4483Department of Molecular and Medical Biotechnology, College of Biotechnology, Al-Nahrain University, Baghdad 10070, IraqDepartment of Plant Biotechnology, College of Biotechnology, Al-Nahrain University, Baghdad 10070, IraqDepartment of Biology, College of Science, Tikrit University, Tikrit 34001, IraqDepartment of Biotechnology, College of Science, University of Anbar, Ramadi 31001, IraqAim: Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality and is characterized by T-cell exhaustion, particularly in effector CD8+ T-cells. This exhaustion, driven by persistent immunosuppressive signals in the tumor microenvironment, impairs immune function and hinders effective immunotherapy. This study aimed to identify key exhaustion-related marker genes in CD8+ T-cells linked to PDAC and assess the potential of repurposing anti-inflammatory drugs to counteract T-cell exhaustion and enhance immune responses against PDAC. Methods: We employed a multi-omics approach, integrating single-cell RNA sequencing data with whole genome sequencing to identify dysregulated exhaustion-related immune markers in CD8+ T-cells in PDAC. We examined gene expression profiles and conducted functional enrichment analysis to evaluate their roles in immune exhaustion. We analyzed mutations in the shortlisted biomarkers from The Cancer Genome Atlas (TCGA) and performed in silico mutational analysis using Maestro to evaluate the impact of an IL7R mutation (K110N) on protein function. Virtual screening using a deep learning framework, GNINA, explored the inhibitory features of the anti-inflammatory drugs oxaprozin and celecoxib on IL7R. Results: Key dysregulated exhaustion-related immune markers were identified including PRF1, GZMA, CD8A, CD3D, NKG7, IL7R, and IL2RG. Pathway enrichment analysis indicated significant involvement in T-cell receptor signaling, Th1 and Th2 differentiation, and Th17 differentiation pathways, correlating with reported poor survival outcomes in PDAC patients. Mutational analysis of IL7R revealed a likely pathogenic mutation (K110N) located in the IL-7Ralpha fibronectin type III domain. Drug repurposing of oxaprozin and celecoxib showed favorable binding interactions with both wild and mutant IL7R proteins. Conclusions: The K110N mutation, despite not causing significant structural changes, may impact T-cell and B-cell homeostasis and development. Our findings suggest that oxaprozin and celecoxib could effectively inhibit T-cell exhaustion through favorable interactions with IL7R. Further clinical studies are necessary to validate the therapeutic potential of these anti-inflammatory drugs in enhancing immune responses in pancreatic cancer.https://www.explorationpub.com/uploads/Article/A1003179/1003179.pdfpancreatic ductal adenocarcinomaeffector cd8+ t-cellsimmunosuppressionexhaustive immune biomarkersanti-inflammatory drugs
spellingShingle Rawaa AlChalabi
Raghda Makia
Semaa A. Shaban
Ahmed AbdulJabbar Suleiman
Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
Exploration of Immunology
pancreatic ductal adenocarcinoma
effector cd8+ t-cells
immunosuppression
exhaustive immune biomarkers
anti-inflammatory drugs
title Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
title_full Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
title_fullStr Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
title_full_unstemmed Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
title_short Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
title_sort characterizing immune biomarkers and effector cd8 t cell exhaustion in pancreatic adenocarcinoma via single cell rna sequencing profiling
topic pancreatic ductal adenocarcinoma
effector cd8+ t-cells
immunosuppression
exhaustive immune biomarkers
anti-inflammatory drugs
url https://www.explorationpub.com/uploads/Article/A1003179/1003179.pdf
work_keys_str_mv AT rawaaalchalabi characterizingimmunebiomarkersandeffectorcd8tcellexhaustioninpancreaticadenocarcinomaviasinglecellrnasequencingprofiling
AT raghdamakia characterizingimmunebiomarkersandeffectorcd8tcellexhaustioninpancreaticadenocarcinomaviasinglecellrnasequencingprofiling
AT semaaashaban characterizingimmunebiomarkersandeffectorcd8tcellexhaustioninpancreaticadenocarcinomaviasinglecellrnasequencingprofiling
AT ahmedabduljabbarsuleiman characterizingimmunebiomarkersandeffectorcd8tcellexhaustioninpancreaticadenocarcinomaviasinglecellrnasequencingprofiling